Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases.
Fatigue and sleep disturbance in multiple sclerosis.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes.
BRBN-T validation: adaptation of the Selective Reminding Test and Word List Generation.
Magnetic resonance imaging in neuromyelitis optica.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Normative data and long-term test-retest reliability of the triple stimulation technique (TST) in multiple sclerosis.
Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Spring cleaning: time to rethink imaging research lines in MS?
STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation.
Probabilistic Multiple Sclerosis Lesion Classification based on Modelling Regional Intensity Variability and Local Neighbourhood Information.
[Neuro-ophthalmology: the eye as a window to the brain].
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis-a computational approach.
CXCL13 antibody for the treatment of autoimmune disorders.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.

Pages